// App-Quantinova.ai

10578 : Exposure to Warfarin and the Risks of Stroke and Bleeding Events among Patients with Non-Valvular Atrial Fibrillation: Real-World vs. Clinical Trial

Researchers

Presenter

  • Luke Boulanger

Principal Investigators

  • Elyse Gatt

  • Dinara Makenbaeva

  • Michael Stokes

  • Daniel Wiederkehr

  • Ning Wu

  • John Graham

Medical Centers

  • University California, Irvine, Irvine, CA

  • United BioSource Corporation, Lexington, MA

  • Montreal, Canada

Locations

  • United States

  • Canada

Companies

  • Pfizer Inc.

  • Bristol-Myers Squibb

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Non-valvular atrial fibrillation

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • apixaban

  • Warfarin

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved